DVx Inc. engages in the research and development, design, purchasing/selling, import/export, repair, maintenance and inspection, and rental of medical devices and related peripheral devices in Japan. The company offers arrhythmia-related products, such as cardiac pacemakers, implantable cardioverter defibrillators, electrode catheters, and ablation catheters; ischemia-related products, that includes RAQUOS and resolution/resolution SD; and EPS Trainer, an intracardiac electrograms simulator; and wonder belt products. The company also engages in the design, manufacture, and purchasing/selling of medical computers; manufacture, purchasing/selling, repair, maintenance and inspection, rental, leasing, and import/export of medicines, quasi drugs, cosmetics, health foods, daily goods, nursing care products, and nursing care equipment; provision of internal and external medical and medical device-related general consulting and services, as well as medical publishing and market research services; and sale and purchase of second hand goods. The company was incorporated in 1986 and is headquartered in Tokyo, Japan.
Research context
DVx Inc appears in PyInvesting’s Tokyo Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- JPY
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Visit company website
5 years, 6 months ago
DVx Inc is currently in a long term downtrend where the price is trading 5.2% below its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.3.
DVx Inc's total revenue sank by 1.8% to $11B since the same quarter in the previous year.
Its net income has increased by 1.1% to $236M since the same quarter in the previous year.
Based on the above factors, DVx Inc gets an overall score of 2/5.